TMEM16 proteins: Ca2+‑activated chloride channels and phospholipid scramblases as potential drug targets (Review).

IF 5.8 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL International journal of molecular medicine Pub Date : 2024-10-01 Epub Date: 2024-08-02 DOI:10.3892/ijmm.2024.5405
Zeqi Huang, Zoya Iqbal, Zhe Zhao, Xiaoqiang Chen, Ayesha Mahmmod, Jianquan Liu, Wencui Li, Zhiqin Deng
{"title":"TMEM16 proteins: Ca<sup>2+</sup>‑activated chloride channels and phospholipid scramblases as potential drug targets (Review).","authors":"Zeqi Huang, Zoya Iqbal, Zhe Zhao, Xiaoqiang Chen, Ayesha Mahmmod, Jianquan Liu, Wencui Li, Zhiqin Deng","doi":"10.3892/ijmm.2024.5405","DOIUrl":null,"url":null,"abstract":"<p><p>TMEM16 proteins, which function as Ca<sup>2+</sup>‑activated Cl<sup>‑</sup> channels are involved in regulating a wide variety of cellular pathways and functions. The modulators of Cl<sup>‑</sup> channels can be used for the molecule‑based treatment of respiratory diseases, cystic fibrosis, tumors, cancer, osteoporosis and coronavirus disease 2019. The TMEM16 proteins link Ca<sup>2+</sup> signaling, cellular electrical activity and lipid transport. Thus, deciphering these complex regulatory mechanisms may enable a more comprehensive understanding of the physiological functions of the TMEM16 proteins and assist in ascertaining the applicability of these proteins as potential pharmacological targets for the treatment of a range of diseases. The present review examined the structures, functions and characteristics of the different types of TMEM16 proteins, their association with the pathogenesis of various diseases and the applicability of TMEM16 modulator‑based treatment methods.</p>","PeriodicalId":14086,"journal":{"name":"International journal of molecular medicine","volume":"54 4","pages":""},"PeriodicalIF":5.8000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11315658/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of molecular medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3892/ijmm.2024.5405","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

TMEM16 proteins, which function as Ca2+‑activated Cl channels are involved in regulating a wide variety of cellular pathways and functions. The modulators of Cl channels can be used for the molecule‑based treatment of respiratory diseases, cystic fibrosis, tumors, cancer, osteoporosis and coronavirus disease 2019. The TMEM16 proteins link Ca2+ signaling, cellular electrical activity and lipid transport. Thus, deciphering these complex regulatory mechanisms may enable a more comprehensive understanding of the physiological functions of the TMEM16 proteins and assist in ascertaining the applicability of these proteins as potential pharmacological targets for the treatment of a range of diseases. The present review examined the structures, functions and characteristics of the different types of TMEM16 proteins, their association with the pathogenesis of various diseases and the applicability of TMEM16 modulator‑based treatment methods.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
TMEM16 蛋白:作为潜在药物靶点的 Ca2+ 激活的氯离子通道和磷脂扰乱酶(综述)。
TMEM16 蛋白作为 Ca2+ 激活的 Cl- 通道参与调节多种细胞通路和功能。Cl- 通道的调节剂可用于呼吸系统疾病、囊性纤维化、肿瘤、癌症、骨质疏松症和冠状病毒疾病的分子治疗 2019。TMEM16 蛋白将 Ca2+ 信号、细胞电活动和脂质转运联系在一起。因此,破译这些复杂的调控机制可使人们更全面地了解 TMEM16 蛋白的生理功能,并有助于确定这些蛋白是否可作为治疗一系列疾病的潜在药理靶点。本综述探讨了不同类型 TMEM16 蛋白的结构、功能和特征,它们与各种疾病发病机制的关联以及基于 TMEM16 调节剂的治疗方法的适用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International journal of molecular medicine
International journal of molecular medicine 医学-医学:研究与实验
CiteScore
12.30
自引率
0.00%
发文量
124
审稿时长
3 months
期刊介绍: The main aim of Spandidos Publications is to facilitate scientific communication in a clear, concise and objective manner, while striving to provide prompt publication of original works of high quality. The journals largely concentrate on molecular and experimental medicine, oncology, clinical and experimental cancer treatment and biomedical research. All journals published by Spandidos Publications Ltd. maintain the highest standards of quality, and the members of their Editorial Boards are world-renowned scientists.
期刊最新文献
Advances in RPGR gene therapy for X‑linked retinitis pigmentosa: From preclinical insights to clinical application (Review). Role of cuproptosis in digestive system tumors (Review). The GPR124‑Wnt‑PPARγ regulatory axis: Molecular mechanisms and therapeutic implications in chronic inflammatory diseases (Review). Environmental exposure to air pollution and climate: Intersecting the impact on ear and nose health and chemosensory function (Review). Role and mechanisms of ferroptosis in cognitive impairment: From molecular pathways to therapeutic targets (Review).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1